PMDA drug package insert
リフキシマ錠200mg
PMDA Prescription drug · あすか製薬株式会社 · package insert Mar 26, 2024
Key facts
| Brand names | リフキシマ錠200mg |
|---|---|
| Nonproprietary names | リファキシミン |
| Companies | 製造販売元／あすか製薬株式会社, 販売元／武田薬品工業株式会社, 提携先／Alfasigma S.p.A |
| Product type | Prescription drug |
| Therapeutic category | 難吸収性リファマイシン系抗菌薬 |
| Therapeutic category codes | 87619 |
| YJ codes | 6199001F1026 |
| Approval numbers | 22800AMX00701 |
| Package insert edition | 第3版 |
| Package insert date | Mar 26, 2024 |
| PMDA document key | 470007_6199001F1026_1 |
| PMDA company code | 470007 |
At a glance
- 1–9 Package insert revisions
- 1–9 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: